Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
TrivarX Limited ( (AU:TRI) ) has provided an announcement.
TrivarX Limited has announced a change to its board, with director John Mathias ceasing to serve as a director effective 31 December 2025. At the time of his departure, Mathias held 2.5 million options in TrivarX, expiring in December 2028 at an exercise price of $0.025, as well as a beneficial interest in 84,850 fully paid ordinary shares held through National Financial Services, and no interests in relevant contracts were disclosed, providing investors with clarity on his residual exposure to the company following his exit.
More about TrivarX Limited
TrivarX Limited is an Australia-listed company; the filing does not specify its industry, products, services or market focus.
Average Trading Volume: 3,176,104
Technical Sentiment Signal: Sell
Current Market Cap: A$23.07M
Learn more about TRI stock on TipRanks’ Stock Analysis page.

